Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

13.65
+0.22001.64%
Post-market: 13.650.00000.00%19:30 EDT
Volume:648.58K
Turnover:8.85M
Market Cap:732.05M
PE:-3.10
High:13.82
Open:13.42
Low:13.36
Close:13.43
52wk High:24.27
52wk Low:12.51
Shares:53.63M
Float Shares:40.15M
Volume Ratio:0.75
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4100
EPS(LYR):-5.8400
ROE:-36.27%
ROA:-18.50%
PB:1.63
PE(LYR):-2.34

Loading ...

Avalo Therapeutics files to sell 128,189 shares of common stock for holders

TIPRANKS
·
Jul 18

What Avalo Therapeutics (AVTX)'s Russell Index Additions and Board Refresh Mean for Shareholders

Simply Wall St.
·
Jul 08

U.S. Stocks on the Move-core Natural Resources, Grabagun, Terawulf

Reuters
·
Jul 06

Leerink Starts Avalo at "outperform" on Skin Disease Drug Potential

Reuters
·
Jul 06

Avalo Therapeutics Inc : Leerink Partners Initiates Coverage with Outperform Rating; Target Price $38

THOMSON REUTERS
·
Jul 06

Avalo Therapeutics CMO Mittie Doyle Disposes of 4,654 Common Shares Valued at $93,080

Reuters
·
Jul 03

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

THOMSON REUTERS
·
Jun 26

Avalo Therapeutics CMO Mittie Doyle Disposes of 1,450 Common Shares Valued at $26,100

Reuters
·
Jun 26

Avalo Therapeutics Director Philip Ron M Files Initial Beneficial Ownership Statement

Reuters
·
Jun 26

Avalo Therapeutics appoints Ron Philip to board of directors

Reuters
·
Jun 23

Avalo Therapeutics Appoints Ron Philip to Board of Directors

THOMSON REUTERS
·
Jun 23

Avalo Therapeutics posts corporate deck highlighting IL-1β pipeline in hidradenitis suppurativa

Reuters
·
Jun 16

Avalo Therapeutics - to Submit Ind Application for Avtx-10 in First Half of 2027

THOMSON REUTERS
·
Jun 16

Avalo Therapeutics Expands Pipeline With Avtx-010, a Long-Acting Next-Generation Anti-Il-1Β Antibody

THOMSON REUTERS
·
Jun 16

Avalo Therapeutics targets 1H 2027 IND for long-acting anti-IL-1β antibody AVTX-010

Reuters
·
Jun 16

Kratos, AMD, CCEP, Avalo, WSM Trending With Analysts

TIPRANKS
·
Jun 13

Avalo Therapeutics amends executive employment deals, boosts change-in-control severance terms

Reuters
·
Jun 13

Avalo Therapeutics' Lead Drug now a Cleaner Immunology Story, BofA Says

MT Newswires Live
·
Jun 12

Avalo Therapeutics : Bofa Global Research Initiates Coverage With Buy Rating and Price Objective $35.00

THOMSON REUTERS
·
Jun 12

Avalo Therapeutics initiated with a Buy at BofA

TIPRANKS
·
Jun 12